Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event ...

A statewide immunization program for infants against respiratory syncytial virus (RSV), which began in 2024, has already ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Universal immunisation with nirsevimab significantly reduces hospitalizations and paediatric intensive care admissions for ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

Adults with RSV-associated acute respiratory infection face a 2.7-fold higher risk for death within one year, according to a ...

The new three-illness dashboard includes a history of outbreaks for any or all of the three respiratory illnesses. It ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

As of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for children and pregnant women.

U.S. Department of Health and Human Services secretary Robert F. Kennedy, Jr announced on Tuesday that COVID vaccines will be ...

At current levels, GRFS scores over ADMA with cheaper valuation, a broad portfolio, and strong EPS growth estimates despite the latter's robust Asceniv-driven momentum.